Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 750 of 542236 entries
View as:

Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

Phase: N/A Priority: Normal
NCT ID: NCT04045561 Org: User:
Start: 06/01/15 End: 12/31/16 Due: 12/31/17

A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04093466 Org: User:
Start: 04/27/20 End: 12/31/25 Due: 12/31/26

Evaluation of a Novel Method for Hematocrit Level Determination

Phase: N/A Priority: Normal
NCT ID: NCT01026883 Org: User:
Start: 04/30/10 End: 11/30/12 Due: 11/30/13

Effects of BCG on Immune Response

Phase: N/A Priority: Normal
NCT ID: NCT02085590 Org: User:
Start: 03/31/14 End: 11/30/14 Due: 11/30/15

Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT06554288 Org: User:
Start: 10/15/24 End: 10/31/26 Due: 10/31/27

Evaluating Changes in Skeletal Muscle Proteins Following Resistance Exercise and Single-Leg Disuse

Phase: N/A Priority: Normal
NCT ID: NCT06350591 Org: User:
Start: 04/01/24 End: 09/30/25 Due: 09/30/26

A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00743496 Org: User:
Start: 10/08/08 End: 04/18/14 Due: 04/18/15

Internet-delivered Group Counseling for Chronic Tinnitus

Phase: N/A Priority: Normal
NCT ID: NCT04382807 Org: User:
Start: 05/12/20 End: 12/31/25 Due: 12/31/26

The Impact of ESP on Neurophysiological Monitoring in Scoliotic Patients

Phase: N/A Priority: Normal
NCT ID: NCT05632016 Org: User:
Start: 10/01/22 End: 03/31/23 Due: 03/31/24

The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01938911 Org: User:
Start: 11/30/14 End: 06/30/16 Due: 06/30/17

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.

Phase: N/A Priority: Normal
NCT ID: NCT05043688 Org: User:
Start: 09/01/21 End: 12/31/30 Due: 12/31/31

A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04688086 Org: User:
Start: 12/15/18 End: 01/30/20 Due: 01/30/21

A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT05201170 Org: User:
Start: 12/30/21 End: 11/21/23 Due: 11/21/24

Systemic Metabolic Contribution From Continuous Renal Replacement Therapy (CRRT)

Phase: N/A Priority: Normal
NCT ID: NCT02998346 Org: User:
Start: 04/30/14 End: 06/28/17 Due: 06/28/18

Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis

Phase: N/A Priority: Normal
NCT ID: NCT02704338 Org: User:
Start: 04/30/16 End: 10/31/18 Due: 10/31/19

Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission

Phase: N/A Priority: Normal
NCT ID: NCT02632396 Org: User:
Start: 03/01/16 End: 08/31/24 Due: 08/31/25

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03120949 Org: User:
Start: 07/04/17 End: 09/01/21 Due: 09/01/22

Efficacy & Cost Effectiveness of Antimicrobial-impregnated CVCs in CLABSI Prevention in a Malaysia Adult ICU

Phase: N/A Priority: Normal
NCT ID: NCT05959018 Org: User:
Start: 01/19/24 End: 12/31/25 Due: 12/31/26

Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05417555 Org: User:
Start: 09/01/22 End: 07/31/26 Due: 07/31/27

An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02103426 Org: User:
Start: 12/30/13 End: 05/10/16 Due: 05/10/17

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03467789 Org: User:
Start: 10/01/18 End: 01/06/23 Due: 01/06/24

Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure

Phase: N/A Priority: Normal
NCT ID: NCT04679597 Org: User:
Start: 01/01/16 End: 12/31/19 Due: 12/31/20

Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05889221 Org: User:
Start: 10/23/23 End: 07/01/28 Due: 07/01/29

Comparative Effects of Aspirin and NHP-544C

Phase: N/A Priority: Normal
NCT ID: NCT02189122 Org: User:
Start: 07/31/14 End: 07/31/15 Due: 07/31/16

Phase I Clinical Protocol of BCG-PPD in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT04593771 Org: User:
Start: 10/21/20 End: 05/24/21 Due: 05/24/22